About EMPE Diagnostics
EMPE Diagnostics is a Healthcare company based in Solna (Sweden) founded in 2015 by Pavan Asalapuram. Point-of-care tests for TB mutation detection are developed. EMPE Diagnostics has raised $1.15 million across 5 funding rounds from investors including European Union, EIC Fund and Almi Invest. The company has 27 employees. Its chief executive, as recorded, is Pavan Asalapuram. Its Indian entity Empe Diagnostics Private Limited reported revenue of ₹11.93 Cr. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Bacterial.
Company details
EMPE Diagnostics was founded in 2015 in Solna, Sweden, within the medical diagnostics sector. Focus is placed on early-stage, point-of-care confirmatory tests for infectious diseases, particularly antimicrobial resistance in tuberculosis. The miniMDR-TB product identifies key mutations like rpoB 531 and katG 315 via visual signals on lateral flow strips in under 60 minutes. The miniXDR-TB test extends detection to multiple genetic markers in microscopy-positive samples during the same timeframe.
- Headquarters Solna, Sweden
- Employees 27
- Founders Pavan Asalapuram
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website empediagnostics.com
- Social LinkedIn
- Legal Name Empe Diagnostics Private Limited
- Date of Incorporation 30 Oct, 2019
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹11.93 Cr
FY 2024 · +107% YoY
- Indian entity net profit₹92.9 Lakh
FY 2024 · 8% margin
- Indian entity EBITDA₹1.62 Cr
FY 2024 · 14% margin
- Total Equity Funding$1.15M (USD)
in 5 rounds
- Latest Funding Round$52.86K (USD), Grant
Feb 2023
- InvestorsEuropean Union
& 2 more
- Employee Count27
Associated legal entities of EMPE Diagnostics
EMPE Diagnostics operates through Empe Diagnostics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Empe Diagnostics Private Limited CIN U33309TG2019PTC149550 | Active | 30 Oct 2019 | Hyderabad, Telangana | ₹11.9 Cr | 27 | 2 | View details |
Funding Insights of EMPE Diagnostics
EMPE Diagnostics has successfully raised a total of $1.15M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $52.86 thousand completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.15M
- Total Rounds 5
- Last Round Grant — $52,863
- First Round $1.15M
(Jun 2018)
- Investors Count 3
All 5 funding rounds of EMPE Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2023 | $52,863 | Grant | – | – | |
| Mar 2020 | $55,114 | Grant | – | – | |
| Dec 2019 | $55,095 | Grant | – | – | |
| Jan 2019 | $26,360 | Grant | – | – | |
| Jun 2018 | $1.15M | Series A | – | Almi Invest | – |
3 investors in total: 3 institutional.
Investors in EMPE Diagnostics
EMPE Diagnostics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, EIC Fund and Almi Invest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Multiple sectors are invested in by corporate-backed Almi Invest. | almi.se/Almi-Invest/ | Lund, Sweden | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for EMPE Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Empe Diagnostics Private Limited (EMPE Diagnostics)
Empe Diagnostics Private Limited is the primary company behind EMPE Diagnostics. The board of Empe Diagnostics Private Limited currently have 2 directors; the longest-serving is Jan Buch Andersen, appointed in 2024. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jan Buch Andersen DIN 10733084 | Director | 19 Aug 2024 | 2 yrs 2 mo | Empe Diagnostics Private Limited |
| Chandran Dev DIN 10733088 | Director | 19 Aug 2024 | 2 yrs 2 mo | Empe Diagnostics Private Limited |
People of EMPE Diagnostics
21 people are tracked at EMPE Diagnostics (3 in leadership, 10 in board & advisors, 8 in team); the tracked headcount is 27.
| Name | Role | Group |
|---|---|---|
Pavan Asalapuram | Co-Founder & CEO | Leadership |
Catharina Lagerstam | CFO & Chairman, Sweden | Leadership |
Sven Hoffner | Director of Clinical Affairs | Leadership |
Rakesh Kumar Srivastava | Advisor | Board & advisors |
Jenny Göransson | Advisor | Board & advisors |
Rahagvendra Goud | Advisor | Board & advisors |
Sanjeev Kumar Gupta | Advisor & Board Member, India | Board & advisors |
Mats Nilsson | Founder | Board & advisors |
Anna Lyander | Advisor | Board & advisors |
Jose Domínguez | Advisor | Board & advisors |
Mona Wilcke | Advisor | Board & advisors |
Sharda Balaji | Board Member, India | Board & advisors |
RK Srivastava | Advisor | Board & advisors |
Gayathri Ramasubban | Manger of Clinical Affairs, India | Team |
Lydia Prasanna | Manager of QA & RA, India | Team |
Bharath Narikimilli | Accounts & Operations Officer, India | Team |
Shekar Patteti | Maintenance Executive | Team |
Munidas Chennappa | Maintenance Executive | Team |
Vandana Balaji Bavisetti | Senior Quality Control Analyst | Team |
Maithreyi Iyer | Research Associate | Team |
1 more people are available in the full profile.
Complete people profiles for EMPE Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of EMPE Diagnostics
Figures of Empe Diagnostics Private Limited, the primary company behind EMPE Diagnostics, for FY 2024. Revenue was ₹11.93 Cr (+107% year on year). Net profit was ₹92.9 Lakh (8% margin). EBITDA was ₹1.62 Cr (14% margin).
- ₹11.93 CrRevenue · FY 2024 · +107% YoY
- ₹92.9 LakhNet profit · 8% margin
- ₹1.62 CrEBITDA · 14% margin
- ₹2.44 CrPaid-up capital
- 27Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Empe Diagnostics Private Limited are on its company page.
Detailed financial statements for EMPE Diagnostics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of EMPE Diagnostics
3 dated milestones of EMPE Diagnostics across 8 years, from founding to its latest funding, stage changes and deals.
- Founded EMPE Diagnostics is founded.
- Funding First funding round of $1.2M.
- Funding Latest funding round, Grant, of $53K.
Web traffic of EMPE Diagnostics
The website of EMPE Diagnostics (empediagnostics.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 1626.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Empe Diagnostics
Complete news archive for EMPE Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EMPE Diagnostics
EMPE Diagnostics was founded in 2015 and raised its 1st funding round 3 years after it was founded.
EMPE Diagnostics is headquartered in Solna, Sweden.
Pavan Asalapuram is the CEO of EMPE Diagnostics, as recorded in our data. They have also founded this company.
EMPE Diagnostics is a funded company, having raised a total of $1.15M across 5 funding rounds to date. The company's 1st funding round was a Series A of $1.15M, raised on Jun 2018.
EMPE Diagnostics has 27 employees.
The primary company behind EMPE Diagnostics, Empe Diagnostics Private Limited, reported revenue of ₹11.93 Cr for FY 2024, up 107% year on year.
EMPE Diagnostics was founded in 2015 in Solna, Sweden, within the medical diagnostics sector. Focus is placed on early-stage, point-of-care confirmatory tests for infectious diseases, particularly antimicrobial resistance in tuberculosis. The miniMDR-TB product identifies key mutations like rpoB 531 and katG 315 via visual signals on lateral flow strips in under 60 minutes. The miniXDR-TB test extends detection to multiple genetic markers in microscopy-positive samples during the same timeframe.
EMPE Diagnostics has 3 investors. Key investors include European Union, EIC Fund, and Almi Invest.
EMPE Diagnostics operates through Empe Diagnostics Private Limited.
The legal entities of EMPE Diagnostics currently have 2 directors, including Jan Buch Andersen, Chandran Dev.